HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of apoptotic cell death by 2'-hydroxycinnamaldehyde is involved with ERK-dependent inactivation of NF-kappaB in TNF-alpha-treated SW620 colon cancer cells.

Abstract
2'-Hydroxycinnamaldehyde (HCA) inhibits cell growth of several human cancer cells with unknown mechanisms. We investigated the inhibitory effect of HCA on TNF-alpha-induced cell growth and possible signal pathway in SW620 colon cancer cells. HCA inhibited TNF-alpha-induced SW620 colon cell growth in time- and dose-dependent manner through induction of apoptotic cell death. Parallel with inhibitory effect on cell growth, HCA dose dependency inhibited TNF-alpha-induced activation of NF-kappaB accompanied with inhibition of the translocation of p50. HCA also induced expression of caspase-3 and Bax, but decreased Bcl-2. HCA furthermore activated ERK pathway, and ERK inhibitor reversed inhibitory effect of HCA on cell growth and transcriptional activation of NF-kappaB. These results demonstrate that HCA inhibits cell growth through induction of apoptotic cell death by ERK pathway-dependent NF-kappaB inactivation.
AuthorsSeung Ho Lee, Chung Woo Lee, Jae Woong Lee, Myoung Suk Choi, Dong Ju Son, Youn Bok Chung, Chong Kil Lee, Ki Wan Oh, Dong Chul Moon, Byoung Mog Kwon, Jin Tae Hong
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 70 Issue 8 Pg. 1147-57 (Oct 15 2005) ISSN: 0006-2952 [Print] England
PMID16143316 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cinnamates
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • p-hydroxycinnamaldehyde
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Apoptosis (drug effects)
  • Blotting, Western
  • Cell Line, Tumor
  • Cinnamates (pharmacology)
  • Colonic Neoplasms (enzymology, pathology)
  • Electrophoretic Mobility Shift Assay
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Humans
  • NF-kappa B (antagonists & inhibitors)
  • Tumor Necrosis Factor-alpha (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: